Letryl 2.5 mg Tablet 5's
₹147.6*
MRP ₹164
10% off
₹139*
MRP ₹164
15% CB
₹25 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Letryl 2.5 mg Tablet 5's belongs to the group of anti-cancer medicines called aromatase inhibitors used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Letryl 2.5 mg Tablet 5's contains 'Letrozole' that works by blocking the aromatase enzyme, which is involved in the production of the estrogen hormone. The cancer cells require estrogen for their growth. Hence, by blocking the aromatase enzyme, Letryl 2.5 mg Tablet 5's prevents the growth of cancer cells. Thereby Letryl 2.5 mg Tablet 5's helps in preventing or stopping the growth of spreading the tumours (cancer cells) to other body parts.
You are advised to take Letryl 2.5 mg Tablet 5's for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, Letryl 2.5 mg Tablet 5's may cause certain common side-effects such as hypercholesterolemia (increased cholesterol levels), tiredness, weakness, increased sweating, feeling unwell, pain in joints, and hot flushes (feeling of warmth). Do not be reluctant to talk with your doctor if you experience any of these side-effects persistently.
Avoid taking Letryl 2.5 mg Tablet 5's if you are pregnant or breastfeeding. Letryl 2.5 mg Tablet 5's may cause drowsiness and dizziness, so drive only if you are alert. Letryl 2.5 mg Tablet 5's should not be given to children as safety has not been established. Avoid consuming alcohol along with Letryl 2.5 mg Tablet 5's as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications to rule out any side-effects.
Letryl 2.5 mg Tablet 5's belongs to the group of anti-cancer medicines called aromatase inhibitors. Letryl 2.5 mg Tablet 5's is used to treat breast cancer in women who have gone through menopause (cessation of periods). Letryl 2.5 mg Tablet 5's works by blocking the aromatase enzyme, which is involved in the production of estrogens. The cancer cells require estrogen for their growth, so by blocking the enzyme Letryl 2.5 mg Tablet 5's prevents the growth of cancer cells. Thereby, Letryl 2.5 mg Tablet 5's helps in slowing down or stopping the growth and/or spreading the tumours to other body parts.
Do not take Letryl 2.5 mg Tablet 5's if you are allergic to any of its contents, if you have not yet gone through menopause (still get your periods). Talk to your doctor before taking Letryl 2.5 mg Tablet 5's if you have osteoporosis (thinning of bones), bone fractures, severe liver or kidney disease. Letryl 2.5 mg Tablet 5's may cause inflammation in tendons or tendon injury; contact your doctor if you observe any sign of tendon pain or swelling while taking Letryl 2.5 mg Tablet 5's. Avoid taking Letryl 2.5 mg Tablet 5's if you are pregnant or breastfeeding. Letryl 2.5 mg Tablet 5's may cause drowsiness and dizziness, so drive only if you are alert. Letryl 2.5 mg Tablet 5's should not be given to children as safety has not been established. Avoid consuming alcohol along with Letryl 2.5 mg Tablet 5's as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications before taking Letryl 2.5 mg Tablet 5's to rule out any side-effects.
Drug-Drug Interactions: Letryl 2.5 mg Tablet 5's may interact with antidepressants (citalopram, escitalopram) and anticancer (tamoxifen).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have high cholesterol, osteoporosis (thinning of bone), or liver disease.
Breast cancer: It is a type of cancer that develops in breast cells which are stimulated by the female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast. The tumour cells invade other healthy breast cells and can travel to lymph nodes which are a primary pathway for the cancer cells to move to other parts of the body. Symptoms of breast cancer include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking Letryl 2.5 mg Tablet 5's to avoid unpleasant side effects. Alcohol intake, along with Letryl 2.5 mg Tablet 5's, may cause increased drowsiness.
Pregnancy
Unsafe
Letryl 2.5 mg Tablet 5's is pregnancy category D medicine so, should not be taken during pregnancy.
Breast Feeding
Unsafe
Letryl 2.5 mg Tablet 5's should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby.
Driving
Caution
Letryl 2.5 mg Tablet 5's may cause dizziness and drowsiness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Safe if prescribed
It is safe to take Letryl 2.5 mg Tablet 5's if prescribed. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Safe if prescribed
It is safe to take Letryl 2.5 mg Tablet 5's if prescribed. Please consult your doctor if you have kidney impairment or any concerns regarding this. No dosage adjustment is required for kidney patients with creatinine clearance greater than 10 mL/min.
Children
Unsafe
Letryl 2.5 mg Tablet 5's should not be used by children, as the efficacy and safety have not been established.
Product Substitutes